These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6840935)

  • 1. Observations on the immunomodulator NPT 15392 in New Zealand Black mice.
    Jones C; Lee C; Hoehler F; Koyama P; Skinner W; Lamott JA
    Int J Immunopharmacol; 1983; 5(1):85-90. PubMed ID: 6840935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enlargement of Lyt-2-positive T cells is associated with functional impairment and autoimmune hemolytic anemia in New Zealand Black mice.
    McCoy KL; Baker PJ; Malek TR; Chused TM
    J Immunol; 1985 Oct; 135(4):2432-7. PubMed ID: 3928748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of erythrocyte autoantibodies in NZB mice: spectrotype and relationship with the Xid gene.
    Bray KR; Gershwin ME; Castles JJ; Ohsugi Y
    Exp Clin Immunogenet; 1984; 1(2):83-9. PubMed ID: 6400995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse.
    Perry FE; Barker RN; Mazza G; Day MJ; Wells AD; Shen CR; Schofield AE; Elson CJ
    Eur J Immunol; 1996 Jan; 26(1):136-41. PubMed ID: 8566056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice.
    DeHeer DH; Edgington TS
    J Immunol; 1977 May; 118(5):1858-63. PubMed ID: 323360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic regulation of anti-erythrocyte autoantibodies and splenomegaly in autoimmune hemolytic anemia-prone new zealand black mice.
    Ochiai K; Ozaki S; Tanino A; Watanabe S; Ueno T; Mitsui K; Toei J; Inada Y; Hirose S; Shirai T; Nishimura H
    Int Immunol; 2000 Jan; 12(1):1-8. PubMed ID: 10607744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lbw2 locus promotes autoimmune hemolytic anemia.
    Scatizzi JC; Haraldsson MK; Pollard KM; Theofilopoulos AN; Kono DH
    J Immunol; 2012 Apr; 188(7):3307-14. PubMed ID: 22371393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for regulation of the autoimmune anti-erythrocyte response by idiotype-specific suppressor T cells in NZB mice.
    Calkins CE; Cochran SA; Miller RD; Caulfield MJ
    Int Immunol; 1990; 2(2):127-33. PubMed ID: 2150924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific anti-erythrocyte focus formation as a measure of autoantibody secreting cells in NZB mice.
    Moore J; Calkins C
    Clin Exp Immunol; 1985 Jan; 59(1):153-60. PubMed ID: 4038633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD4 treatment of NZB mice prevents the development of erythrocyte autoantibodies but hastens the appearance of anaemia.
    Oliveira GG; Hutchings PR; Lydyard PM
    Immunol Lett; 1994 Feb; 39(2):153-6. PubMed ID: 7912223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the spontaneous autoimmune (anti-erythrocyte) response in NZB mice using a pathogenic monoclonal autoantibody and its anti-idiotype.
    Caulfield MJ; Stanko D; Calkins C
    Immunology; 1989 Feb; 66(2):233-7. PubMed ID: 2925223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-induced murine hemolytic anemia.
    Meryhew NL; Handwerger BS; Messner RP
    J Lab Clin Med; 1984 Oct; 104(4):591-601. PubMed ID: 6481219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo(a)pyrene-induced anemia and splenomegaly in NZB/WF1 mice.
    Booker CD; White KL
    Food Chem Toxicol; 2005 Sep; 43(9):1423-31. PubMed ID: 15936865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular basis of autoimmunity: precocious immunological maturity in NZB mice.
    Jenkinson AM; East J
    J Clin Lab Immunol; 1980 May; 3(3):145-52. PubMed ID: 7420403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms resulting in pathogenic anti-mouse erythrocyte antibodies in New Zealand black mice.
    Scott BB; Sadigh S; Stow M; Mageed RA; Andrew EM; Maini RN
    Clin Exp Immunol; 1993 Jul; 93(1):26-33. PubMed ID: 8324901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon treatment of NZB mice: accelerated progression of autoimmune disease.
    Heremans H; Billiau A; Colombatti A; Hilgers J; de Somer P
    Infect Immun; 1978 Sep; 21(3):925-30. PubMed ID: 213392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific and non-specific suppressor cell activity in NZB mice.
    Cooke A; Hutchings P; Nayak R
    Immunology; 1980 Jul; 40(3):335-42. PubMed ID: 6159307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice.
    Youssef AR; Shen CR; Lin CL; Barker RN; Elson CJ
    Clin Exp Immunol; 2005 Jan; 139(1):84-9. PubMed ID: 15606617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of autoimmune hemolytic anemia in New Zealand black mice.
    Izui S; Reininger L; Shibata T; Berney T
    Crit Rev Oncol Hematol; 1994 Aug; 17(1):53-70. PubMed ID: 7986360
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro regulation of the pathogenic autoantibody response of New Zealand black mice. I. Loss with age of suppressive activity in T cell populations.
    Moore JS; Calkins CE
    J Immunol; 1985 Jun; 134(6):3838-44. PubMed ID: 2580897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.